Advertisement
ARDX vs VTGN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and VTGN is a Buy.
ARDX in upward trend: price may jump up because it broke its lower Bollinger Band on October 26, 2026
ARDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 22 of 26 cases where ARDX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARDX's RSI Indicator exited the oversold zone, 23 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 60 cases where ARDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDX advanced for three days, in 224 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARDX as a result. In 62 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for ARDX entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. ARDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.250) is normal, around the industry mean (3.070). P/E Ratio (-13.174) is within average values for comparable stocks, (-1.257). Projected Growth (PEG Ratio) (50.260) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.491) among similar stocks. P/S Ratio (1.846) is also within normal values, averaging (439.237).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
VTGN's RSI Oscillator stays in oversold zone for 6 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VTGN as a result. In 84 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for VTGN turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 33 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
VTGN moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VTGN crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VTGN entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.305) is normal, around the industry mean (3.154). P/E Ratio (-0.101) is within average values for comparable stocks, (-1.071). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.299) among similar stocks. P/S Ratio (3.764) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. VTGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ARDX | VTGN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 81 | 100 | |
SMR RATING 1..100 | 97 | 99 | |
PRICE GROWTH RATING 1..100 | 84 | 93 | |
P/E GROWTH RATING 1..100 | 13 | 18 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VTGN's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for ARDX (97). This means that VTGN’s stock grew somewhat faster than ARDX’s over the last 12 months.
ARDX's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as VTGN (100). This means that ARDX’s stock grew similarly to VTGN’s over the last 12 months.
ARDX's SMR Rating (97) in the Biotechnology industry is in the same range as VTGN (99). This means that ARDX’s stock grew similarly to VTGN’s over the last 12 months.
ARDX's Price Growth Rating (84) in the Biotechnology industry is in the same range as VTGN (93). This means that ARDX’s stock grew similarly to VTGN’s over the last 12 months.
ARDX's P/E Growth Rating (13) in the Biotechnology industry is in the same range as VTGN (18). This means that ARDX’s stock grew similarly to VTGN’s over the last 12 months.
| ARDX | VTGN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 79% | 1 day ago 89% |
| Stochastic ODDS (%) | 2 days ago 82% | 4 days ago 83% |
| Momentum ODDS (%) | 2 days ago 79% | 1 day ago 90% |
| MACD ODDS (%) | N/A | 1 day ago 82% |
| TrendWeek ODDS (%) | 2 days ago 79% | 1 day ago 90% |
| TrendMonth ODDS (%) | 2 days ago 81% | 1 day ago 88% |
| Advances ODDS (%) | 16 days ago 85% | N/A |
| Declines ODDS (%) | 5 days ago 80% | 5 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 85% | N/A |
| Aroon ODDS (%) | 2 days ago 83% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARDX’s FA Score shows that 1 FA rating(s) are green while VTGN’s FA Score has 1 green FA rating(s).
- ARDX’s FA Score: 1 green, 4 red.
- VTGN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARDX’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 2 bullish TA indicator(s).
- ARDX’s TA Score: 4 bullish, 3 bearish.
- VTGN’s TA Score: 2 bullish, 6 bearish.
Price Growth
ARDX (@Biotechnology) experienced а -1.62% price change this week, while VTGN (@Biotechnology) price change was -6.34% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was -14.01%, and the average quarterly price growth was -15.33%.
Reported Earning Dates
ARDX is expected to report earnings on Nov 03, 2026.
VTGN is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+0.20% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ARDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To ARDX | 1D Price Change % | ||
|---|---|---|---|---|
| ARDX | 100% | N/A | ||
| VCYT - ARDX | 45% Loosely correlated | +3.70% | ||
| IMNM - ARDX | 40% Loosely correlated | -2.51% | ||
| CABA - ARDX | 39% Loosely correlated | +4.28% | ||
| MLTX - ARDX | 36% Loosely correlated | +2.11% | ||
| ELVN - ARDX | 36% Loosely correlated | +0.67% | ||
More | ||||